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In a previous study, we have developed a panel of 
chromosomal rearrangements for the physical map­
ping of the ql3-q21 region of the human X chromo­
some (Philippe et al.9 Genomics 17: 147-152, 1993). 
Here, we report the physical localization of 36 addi­
tional polymorphic markers by polymerase chain 
reaction analysis. The high density of chromosomal 
breakpoints in Xq21 allows us to map 58 DNA loci in 
22 intervals. As a result, this segment of the X chromo­
some is saturated with approximately three sequence 
tagged sites per megabase of DNA, which will facilitate 
the construction of a YAC contig of this region. © 1995
Academic Press, Inc.
The Xq21 band is the most prominent, dark staining 
Giemsa band of the human X chromosome. This seg­
ment seems to be relatively devoid of functionally im­
portant genes, as demonstrated by the existence of 
male-viable deletions spanning almost the entire Xq21 
region (3), These deletions very often are associated 
with contiguous gene syndromes consisting of choroide- 
remia (CHM), X-linked mixed deafness (DFN3), and 
nonspecific mental retardation (MR). Together with 
X;autosome translocations (t(X;A)), the deletions were 
instrumental for positional cloning of the CHM gene 
(4, .15), and more recently, the DFN3 gene (6). Genetic 
linkage studies in families with syndromic forms of 
mental retardation, most notably the Allan-Herndon- 
Dudley syndrome locus (21), the Juberg-Marsidi syn­
drome (20), and X-linked a thalassemia/mental retar­
dation (10), suggest a location of these genes in the 
Xql2-q21 region. Whether any of these syndromes and 
nonspecific MR are caused by mutations in the same 
gene remains to be investigated. In addition, the Xq21 
region contains a gene underlying X-linked cleft palate 
and/or ankyloglossia (CPX) (22).
1 To whom correspondence should be addressed. Telephone: (44) 
1865 740 020.
Deletions and translocations have been very useful 
for the improvement of the physical map of the human 
genome, especially for the X chromosome. This is par­
ticularly true for the Xp22, Xp21, and Xq21 regions. We 
have previously developed a panel of 24 X-chromosomal 
rearrangements that, by means of Southern blot analy­
sis, has allowed us to map physically more than 30 
DNA markers within 18 intervals of Xq21 (16). Here 
we report the localization of an additional 26 DNA loci 
in Xq21 with special emphasis on polymorphic mark­
ers. These new markers have been mapped by polymer­
ase chain reaction (PCR) analysis on genomic DNA 
from either lymphoblastoid cell lines of males with in­
terstitial deletions or somatic cell hybrids derived from 
females with X; autosome translocations. The PCR data 
were combined with the hybridization data, Which 
yielded a high-resolution interval map for Xq21.
A reaction volume of 50 jjl was used with 200 ng of 
genomic DNA, 0.25 fig of each primer, 200 fiM deoxy- 
nucleotide triphosphates, lx  PCR buffer specified by 
the Taq DNA polymerase suppliers, and 1 unit of Taq 
DNA polymerase. In most cases, the PCR conditions 
were those described in the original descriptions of the 
different markers. Occasionally, to improve PCR speci­
ficity, we modified either the annealing temperature 
or the MgCl2 concentration. For each DNA marker 
mapped by PCR analysis, controls were carried out 
with a normal female cell line, a hamster cell line, and 
GM06318B, a hybrid cell line containing the X chromo­
some as the sole human component (NIGMS Human 
Genetic Mutant Cell Repository). Fifteen microliters of 
the PCR reaction was analyzed on a 3% agarose gel 
(1.5% Seakem GTG agarose 4- 1.5% Nusieve GTG 
agarose).
A total of 36 sequence tagged sites, STSs, (Table 1) 
including 20 microsatellite markers from the Genethon 
second-generation genetic linkage map (9) have been 
physically mapped to the proximal region of Xq. Most of 
these markers represent short tandem repeats (STR) 
with high heterozygosity that are of interest for linkage
GENOMICS 27, 539-543 (1995)
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TABLE 1
STR and RFLP Loci Mapped by PCR in This Study
Locus Name STR Heterozygosity Reference
DXS262 KZ040 0.27 (RFLP) 1
DXS345" RX72R1 ---------- 0.38 (RFLP) This study
DXS 3 46 RX86 (CA)j7 0.20 1
DXS355 RX167 (TAAAA)4 0.38 (RFLP) 1
DXS364 RX272 (AC) u 0.46 1
DXS441/DXS5666 1 and 2/HX60 (AC)W/(AC)18 0,76/0.68 17, 18
DXS453/DXS983C Mfd66/AFM078zal (AC)aa/(AC)„ 0.63/0.64 9, 25
DXS454 Mfd72 (AC)17G(GA)8 0.59 25
DXS456 XG30B (AC)„ 0.77 14
DXS458 Mfd79 (AC) is A 0.62 25
DXS571/DXS1105rf HX79(BlB2)/AFM263wcl (CA)16/(AC)B 0.46/0.38 5, 9
DXS738 MIT-E114 (CA)17 0.71 12
DXS986 AFM116xgl (AC )„ 0.75 9
DXS988 AFM123xd4 (AC)« 0.60 9
DXS990 AFM136yc7 (AC)» 0.75 9
DXS991 AFM151xfi6 (AC)* 0.81 9
DXS995 AFM207zg5 (AC), 0.60 9
DXS1000 AFM248te9 (AC), 0.34 9
DXS1002 AFM249vh5 (AC), 0.70 9
DXS 10 66 AFM234tf8 (AC )n 0.37 9
DXS 1120 L21174 (AC )23 0.74 7
DXS 1124 L21177 (TG)6TT(TG)17 0.54 7
DXS1167 D3 (AOe^iCA)? 0.03 1
DXS 1168 XKL10 (CA)lflG(CA)M 0.53 1
DXS 1169 A l (CA)19 0.53 1
DXS 1170 B8 (CA)24 0.67 1
DXS 1196 AFM056yb8 (AC)b 0.79 9
DXS 1197 AFM072za5 (AC)n 0.64 9
DXS1203 AFM262vgl (AC)„ 0.65 9
DXS1209 AFlM273zd5 (AC)„ 0.45 9
DXS 1217 AFM288ye9 (AC )„ 0.62 9
DXS 1221 AFM303wdl (AC)„ 0.59 9
DXS 1222 AFM308xb5 (AC), 0.65 9
DXS 1225 AFM311vg5 (AC)n 0.74 9
DXS 1230 AEM337zbl (AC)„ 0.62 9
DXS 1231 AFM340yel (AC)« 0.49 9
Note* The characteristics of the DNA loci are those reported in  the original description of the PCR markers. While our work was in 
progress, several dinucleotide repeats with different DXS number were shown to be identical (see footnotes b -d ).
a The novel STS primer pair for probe RX-72R1 (DXS345) has been developed by D. F. Barker, Utah, (pers. comm,) and is as follows (5' 
3'): RX72Rl(a) F, AGCAACAGCTAATTTCTATGG; RX72Rl(a) R, ACAAACTTTTACCCCTGCT. The PCR was performed as described in 
the text with a final MgCl2 concentration of 1.5 mM, After a first denaturation step (5 min at 94°C), 40 cycles (94°C for 40 s, 53°C for 40 
s) were performed. A final elongation step (5 min a t 72°C) ended the process. 
b Lindsay et a l  (13) have demonstrated that the micro satellite a t DXS566 corresponds to the dinucleotide repeat at DXS441. 
c Rider and Monaco (19) have proved that the dinucleotide repeat at the locus DXS453 is identical to that designated at locus DXS983. 
d Gyapay et al. (9) noted tha t micro satellites at DXS571 and DXS 110 5 are identical.
analysis in families with X-linked diseases located in the 
proximal region of the long arm of the human X chromo­
some. Of the 36 new STSs integrated in the physical map, 
10 are located either proximal to the C56N breakpoint 
or distal to the SN breakpoint. Therefore, with the excep­
tion of DXS441/566, which is deleted in patient RvD, they 
are not included in Fig. 1. Loci DXS453/983, DXS988, 
DXS991, and DXS1000 map proximal to the PMI 
breakpoint (GDB breakpoint 84 not depicted in Fig. 1). 
Loci DX81124 and DXS1221 are located within Xql3 be­
tween the PMI and the C56N breakpoints. Among the 
36 DNA markers tested, DX8456, DXS571, and DXS1120 
are distal to the SN breakpoint (the SN breakpoint is 
located between DXS87 and DXS571 in Xq22.3).
some into 22 ordered intervals from the RvD proximal 
deletion boundary (BXP 93) to the distal deletion 
breakpoints in patients RvD and MBU (BXP 94 and 
BXP 110, respectively) (Fig. 1). Interval 23 corresponds 
to almost the entire Xq22 band, as DXS17 has been 
mapped to Xq22.3 (26). The gradual integration of 24 
STRs and 2 conventional RFLP markers allowed us 
to create 4 additional intervals since the previously 
published map (16). According to the most updated con­
sensus map of the X chromosome (26), BXP 93 is lo­
cated between PGK1 and DXS566 at the boundary be­
tween Xql3.3 and Xq21.1, while both BXP 94 and BXP 
110 (distal deletion breakpoints in RvD and MBU, re­
spectively) are flanked by DXS 118 and DXS454 in the
Our study resolves the Xq21 band of the X chromo- proximal part of Xq22.1.
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FIG. 1. Detailed physical mapping of marker loci in Xq21. Since the previously published map (16), six X-rearrangements have been 
removed from this deletion translocation panel: duplications CN and KM, deletions SD and 33.1, and translocations CIII-1 and HR10. We 
have added one rearrangement, 5513, found in a female carrying a balanced X;autosome translocation, 46,X,t(X;22Xq21.2;pl2), which is 
not associated with any abnormal phenotype. EBV-transformed cells from this female were fused with Wg3h ham ster cells by using 
polyethylene glycol. Hybrid clones containing the der22 as the sole human X component were obtained under HAT (hypoxanthine, aminopter- 
ine, thymidine) selection essentially as described by Benham et a l  (2). At the top an idiogram of the Xq21 region in G-banding is presented. 
For each X-rearrangement the segment of the X chromosome present is indicated by a bar. Within each interval the probes are arranged 
arbitrarily in increasing numerical order. The different disease loci in Xq21 as well as the GDB (Genome Data Base) breakpoint numbers 
(BXP) are depicted at the bottom of the figure. For the BXP numbers, when more than one deletion/translocation breakpoint defines the 
boundary between two intervals, we have chosen a BXP number corresponding to the first X-rearrangement from the top to the bottom of 
the figure (for example, BXP 91 corresponds to the proximal breakpoint of the deletion NP).
The human choroideremia gene (CHM) spans at least 
150 kb in Xq21.2 between DXS165 and DXS1002 (23, 
24). Based on the distal deletion breakpoint (BXP 188) 
in patient MS (24), DXS1002 is located proximal to 
DXS95 in interval 13. From fine mapping of Xq21 dele­
tions associated with complex syndromes (11), interval 
8 contains a gene involved in MR. The X-linked cleft 
palate and/or ankyloglossia (CPX) locus has been 
mapped by linkage analysis between DXS95 and 
DYXS1X (22). The physical map reported in this study 
should facilitate the positional cloning of disease genes 
from the Xq21 region. The positioning of the microsatel­
lite marker AFM207zg5 (DXS995) in interval 6 is a good 
example, as it has been very useful for cloning and char­
acterization of the critical region for DFN3 (11). Very 
recently, by combining positional cloning and candidate 
gene approaches, the POU domain gene BRN4 (8) was 
shown to be implicated in X-linked mixed deafness (6).
The high density of naturally occurring chromosomal 
rearrangements in this segment of the X chromosome 
allowed us to build a high-density map. The physical 
size of the X-chromosomal segment between DXS566 
and DXS118 is estimated to be roughly 15-20 Mb, 
which brings the average size for each interval to less
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than 1 Mb. Moreover, as each interval contains on aver­
age 2.6 DNA markers, this Xq21 map should contain 
1 marker per every 350 kb.
In establishing this translocation/deletion map, we 
have assumed that each rearrangement is not more 
complex than a simple translocation or interstitial dele­
tion. Furthermore, the use of hybrid cell lines for map­
ping needs vigilance as tiny rearrangements are quite 
frequent. For every DNA marker localized, our findings 
are in agreement with all genetic and physical data 
published so far in the proximal region of Xq, and no 
single deletion or translocation gave inconsistent re­
sults when compared to other X-rearrangements, indi­
cating that these rearrangements are not complex. 
Some YAC contigs have been built in Xq21, but several 
gaps remain (26). The detailed physical map presented 
here will be of great value in generating a complete 
YAC contig of the Xq21 region and provides a very 
efficient way to map precisely any new microsatellite 
or expressed sequence tag positioned in the proximal 
part of the long arm of the human X chromosome. Any 
new STS localized in the Xq proximal region can be 
sent to the authors for refined mapping, or, alterna­
tively, DNA samples from the deletion/translocation 
panel are available upon request. This work demon­
strates the importance of chromosome rearrangements 
in human gene mapping.
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